Literature DB >> 556782

Impairment of reovirus mRNA methylation in extracts of interferon-treated Ehrilich ascites tumor cells: further characteristics of the phenomenon.

G C Sen, S Shaila, B Lebleu, G E Brown, R C Desrosiers, P Lengyel.   

Abstract

We reported earlier that the methylation of unmethylated reovirus mRNA (reo mRNAU) by the cellular methylating enzymes is impaired in extracts of uninfected, interferon-treated Ehrilich ascites tumor cells (S30INT). We find now that after the methylation of reo mRNAU has stopped in S30INT, the RNA can be reisolated and further methylated in an extract of control cells (S30C). Thus the impairment of methylation in S30INT cannot be due to cleavage or irreversible inactivation of reo mRNAU. Freshly added reo mRNAU can be methylated in S30INT in which the methylation of previously added reo mRNAU has stopped. This indicates that the impairment is due to the depletion of S-adenosylme thionine (the methyl donor), the accumulation of S-adenosylhomocysteine (an inhibitor of methylation), or the irreversible inactivation of reo mRNAU. Freshly added reo mRNAU can be methylated in S30INT in which the methylation of previously added reo mRNAU has stopped. This indicates that the impairment is not due to the depletion of S-adenosylmethionine (the methyl donor), the accumulation of S-adenoxylhomocysteine (an inhibitor of methylation), or the irreversible inactivation of the methylating enzymes. It may be due, however, to the unavailability of reo mRNAU for methylation. The extent of the impairment of reo mRNAU methylation in S30INT decreases with an increasing concentration of reo mRNAU but is not affected by added poly (U), ribosomal RNA, or encephalomyocarditis virus RNA (an mRNA that is probably not capped or methylated at its 5' end). The methylation of reo mRNAU is also impaired in an extract from cells that have not been treated with interferon but with the interferon inducer poly(I) - poly(C). The inhibitor is apparently a macromolecule that is inactivated during incubation. It decreases the methylation at the 7 position of the 5' terminal guanylate residue. In vitro, the rate of reo mRNA synthesis by reovirus cores in the presence of S30INT is the same as in the presence of S30C. However, the methylation of the de novo synthesized reo mRNA by the core-associated methylating enzyme(s) in vitro is inhibited by S30INT but not by S30C. The relevance of these phenomena to the inhibition of reovirus replication in interferon-treated cells remains to be established.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 556782      PMCID: PMC353792     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Interferon assay based on the inhibition of double-stranded reovirus RNA accumulation in mouse L cells.

Authors:  A Vassef; G Beaud; K Paucker; P Lengyel
Journal:  J Gen Virol       Date:  1973-04       Impact factor: 3.891

2.  Quantitative aspects of interferon-induced plaque reduction: kinetics of interferon action.

Authors:  G W Jordan
Journal:  Virology       Date:  1972-05       Impact factor: 3.616

3.  Sequences containing methylated nucleotides at the 5' termini of messenger RNAs: possible implications for processing.

Authors:  F Rottman; A J Shatkin; R P Perry
Journal:  Cell       Date:  1974-11       Impact factor: 41.582

4.  Temperature-sensitive mutants of reovirus. I. Patterns of gene expression by mutants of groups C, D, and E.

Authors:  Y Ito; W K Joklik
Journal:  Virology       Date:  1972-10       Impact factor: 3.616

5.  Effect of interferon on synthesis of ssRNA in reovirus type 3-infected L cell cultures.

Authors:  C J Gauntt
Journal:  Biochem Biophys Res Commun       Date:  1972-06-09       Impact factor: 3.575

6.  Translation of in vitro synthesized reovirus messenger RNAs into proteins of the size of reovirus capsid proteins in a mouse L cell extract.

Authors:  W D Graziadei; P Lengyel
Journal:  Biochem Biophys Res Commun       Date:  1972-03-10       Impact factor: 3.575

7.  Nutritional effects on the polyribosome distribution and rate of protein synthesis in Ehrlich ascites tumor cells in culture.

Authors:  W J Van Ventrooij; E C Henshaw; C A Hirsch
Journal:  J Biol Chem       Date:  1970-11-25       Impact factor: 5.157

8.  Formation and characteristics of reovirus subviral particles in interferon-treated mouse L cells.

Authors:  R L Galster; P Lengyel
Journal:  Nucleic Acids Res       Date:  1976-03       Impact factor: 16.971

9.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

10.  Protein synthesis directed by encephalomyocarditis virus RNA: properties of a transfer RNA-dependent system.

Authors:  H Aviv; I Boime; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1971-09       Impact factor: 11.205

View more
  15 in total

Review 1.  Antiviral activity of interferons.

Authors:  R M Friedman
Journal:  Bacteriol Rev       Date:  1977-09

Review 2.  Regulation of cell proliferation and differentiation by interferons.

Authors:  M J Clemens; M A McNurlan
Journal:  Biochem J       Date:  1985-03-01       Impact factor: 3.857

Review 3.  The biology of interferon actions.

Authors:  G Gastl; C Huber
Journal:  Blut       Date:  1988-05

4.  Interferon, double-stranded RNA, and RNA degradation: activation of an endonuclease by (2'-5')An.

Authors:  E Slattery; N Ghosh; H Samanta; P Lengyel
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

5.  Inhibition of vaccinia mRNA methylation by 2',5'-linked oligo(adenylic acid) triphosphate.

Authors:  O K Sharma; B B Goswami
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

Review 6.  The interferon renaissance: molecular aspects of induction and action.

Authors:  J Gordon; M A Minks
Journal:  Microbiol Rev       Date:  1981-06

7.  Isolation of two interferon-induced translational inhibitors: a protein kinase and an oligo-isoadenylate synthetase.

Authors:  A Zilberstein; A Kimchi; A Schmidt; M Revel
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

8.  Differential antiviral effects of interferon in three murine cell lines.

Authors:  G C Sen; R E Herz
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

9.  Accumulation of newly synthesized mRNAs in response to human fibroblast (beta) interferon.

Authors:  R J Colonno
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

10.  Presence of double stranded regions of viral RNA in infected cells.

Authors:  S I Koliais
Journal:  Experientia       Date:  1981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.